NEW YORK, NY, January 08, 2014 /24-7PressRelease/
-- Ensil's team of researchers and engineers have developed a medical device with patented technology that will help patients who suffer from mobility issues caused by spinal cord injuries, strokes or muscle disorders.
This product is called Vastusys (www.vastusys.com
), and it works by replicating normal communication between the brain and the limbs via a proprietary, patented technology developed by Ensil. The product utilizes Ensil's innovative bluetooth protocol technology and multiple sensors to enable muscle movement and improve mobility.
"This is truly a ground-breaking achievement that will improve the lives of so many people," said Mr. Farsad Kiani, CEO of Ensil Canada. "I am excited to extend an open invitation to publicly traded companies to either acquire this technology or partner with Ensil to market and distribute this medical device to people around the world."
Ensil is currently inviting publicly traded companies to express interest in either acquiring the new technology or partnering with Ensil on the marketing and/or distribution of the Vastusys medical device.
Ensil Canada is a member of the Ensil group of companies (www.ensil.com
), and it focuses on enhancing mission-critical technologies in the areas of Aerospace, Defence and Medical Diagnostic Equipment. Ensil's Research and Development division's mission is to develop new technologies or improve existing technologies, leveraging its in-house aerospace, defence and medical technology expertise, research and resources.
For nearly 30 years, a fundamental belief in "Innovation Beyond Imagination" has been part of Ensil's corporate culture. Since its inception, the company has built its brand in the North American Aerospace and Defence industries as a boutique engineering and R&D technology leader that is striving to improve the quality of life of people globally via innovative ideas and technologies.